Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win ...

The negotiations for a global pandemic treaty began in December 2021, at a time when the Omicron variant of SARS-CoV-2 was ...

The Food and Drug Administration urges companies to conduct large studies before vaccines are approved for non-high-risk ...

The NIH faces cuts of 35 percent, requested by billionaire Elon Musk’s so-called Department of Government Efficiency (DOGE).

Seattle vaccine experts were confused by the country's apparent new direction around updated COVID-19 shots, which top FDA ...

Today’s Forbes Daily newsletter covers Elon’s pledge to Tesla, a big mortgage bill for Trump, top employers for college grads ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...

A lot happens in Boston every day. To help you keep up, WBUR, Boston's NPR News station, pulled these stories together just for you.

The Department of Disease Control warns of rising Covid-19 cases—nearly 50,000 last week—and expects the outbreak to continue for 2–3 months. Flu cases are steady with 300,000+ infections and 33 ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

Top officials at the FDA outlined a new framework for approving Covid-19 vaccines, saying that the US would make the boosters available for Americans over the age of 65 and for adults and children ...